SURMONTIL 75 75 MG
TRIMIPRAMINE (TRIMIPRAMINE MALEATE) : 75 MG · DIN 01926349 · AVENTIS PHARMA INC
Health Canada status: CANCELLED POST MARKET
What is SURMONTIL 75?
SURMONTIL 75 75 MG contains TRIMIPRAMINE (TRIMIPRAMINE MALEATE) : 75 MG. It is listed in the Health Canada Drug Product Database under DIN 01926349, held by AVENTIS PHARMA INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01926349 |
|---|---|
| Brand name | SURMONTIL 75 |
| Generic / active ingredient | TRIMIPRAMINE (TRIMIPRAMINE MALEATE) : 75 MG |
| Manufacturer | AVENTIS PHARMA INC |
| Strength | 75 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AA06 TRIMIPRAMINE |
| AHFS class | 28:16.04.28 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2005 |
| Original market date | 1979-12-31 00:00:00 |
Is TRIMIPRAMINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by AA PHARMA INC, last seen 13 Apr 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N06AA06 TRIMIPRAMINE. 5 of 32 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TRIMIPRAMINE | 100 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00740829 |
| TRIMIPRAMINE | 12.5 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00740799 |
| TRIMIPRAMINE | 25 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00740802 |
| TRIMIPRAMINE | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00740810 |
| TRIMIPRAMINE | 75 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 02070987 |
| APO-TRIMIPRAMINE | 100 MG | TABLET | APOTEX INC | APPROVED | DIN 02405393 |
| APO-TRIMIPRAMINE | 12.5 MG | TABLET | APOTEX INC | APPROVED | DIN 02405369 |
| APO-TRIMIPRAMINE | 25 MG | TABLET | APOTEX INC | APPROVED | DIN 02405377 |
| APO-TRIMIPRAMINE | 50 MG | TABLET | APOTEX INC | APPROVED | DIN 02405385 |
| APO-TRIMIPRAMINE | 75 MG | CAPSULE | APOTEX INC | APPROVED | DIN 02405407 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.